House FDA reform national uniformity provision acknowledges state tort rights.
This article was originally published in The Rose Sheet
Executive Summary
HOUSE FDA REFORM NATIONAL UNIFORMITY PROVISION ACKNOWLEDGING STATE TORT RIGHTS is included in a revised draft of Rep. Richard Burr's (R-N.C.) drugs and biologics bill (HR 3199). The new draft, released July 10, includes a clarification, which states that "nothing in the [national uniformity] section shall be construed to modify or otherwise affect any action or the liability of any person under the generally applicable tort law of any state."